Brief Report: Potent clinical and radiological response to larotrectinib in TRK fusion-driven high-grade glioma
[Paper-level Aggregated] PMCID: PMC6173734
Evidence Type(s): Oncogenic, Functional
Justification: Oncogenic: The text mentions a pathogenic TP53 missense variant c.422G>A (p.Cys141Tyr), indicating that this variant is associated with tumorigenesis and is likely to contribute to cancer development. Functional: The presence of the pathogenic TP53 variant suggests that it may affect the function of the TP53 protein, which is critical for regulating the cell cycle and preventing tumor formation.
Gene→Variant (gene-first): TP53(7157):c.422G>A TP53(7157):p.Cys141Tyr
Genes: TP53(7157)
Variants: c.422G>A p.Cys141Tyr